XML 47 R31.htm IDEA: XBRL DOCUMENT
v3.20.1

REVISIONS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Accounting Changes and Error Corrections [Abstract] |
Summary of Revisions | A reconciliation of the originally reported amounts to the restated amounts for the adjustments noted above for each of the affected periods is presented below. Consolidated Balance Sheet as of September 30, 2018:
| (In thousands) | As Originally Reported |  | Adjustments |  | As Restated
| ASSETS |  |  |  |  |
| Current assets: |  |  |  |  |
| Cash and cash equivalents | $ | 40,663 |  |  | $ | — |  |  | $ | 40,663 |
| Short term investments | 55,480 |  |  | — |  |  | 55,480 |
| Trade accounts receivable, net | 4,080 |  |  | 59 |  |  | 4,139 |
| Inventories, net | 6,037 |  |  | — |  |  | 6,037 |
| Prepaid expenses and other current assets | 627 |  |  | — |  |  | 627 |
| Total current assets | 106,887 |  |  | 59 |  |  | 106,946 |
| Property and equipment, net | 5,842 |  |  | — |  |  | 5,842 |
| Other assets* | 385 |  |  | — |  |  | 385 |
| Total assets | $ | 113,114 |  |  | $ | 59 |  |  | $ | 113,173 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |
| Current liabilities: |  |  |  |  |
| Accounts payable | $ | 2,348 |  |  | $ | — |  |  | $ | 2,348 |
| Accrued expenses and other current liabilities | 19,324 |  |  | 764 |  |  | 20,088 |
| Total current liabilities | 21,672 |  |  | 764 |  |  | 22,436 |
| Related party note payable | 140 |  |  | — |  |  | 140 |
| Total liabilities | 21,812 |  |  | 764 |  |  | 22,576 |
| STOCKHOLDERS' EQUITY |  |  |  |  |
| Common stock, $0.001 par value; 75,000,000 shares authorized; 33,763,019 issued and 33,620,444 outstanding | 33 |  |  | — |  |  | 33 |
| Additional paid-in capital | 51,798 |  |  | — |  |  | 51,798 |
| Retained earnings | 39,471 |  |  | (705 | ) |  | 38,766 |
| Total stockholders’ equity | 91,302 |  |  | (705 | ) |  | 90,597 |
| Total liabilities and stockholders’ equity | $ | 113,114 |  |  | $ | 59 |  |  | $ | 113,173 |
| * The Company has condensed the presentation of amounts presented in the balance sheet to conform to presentation guidelines.
Consolidated Statement of Operations for the three months ended September 30, 2018:
(In thousands) | As Originally Reported |  | Adjustments |  | As Restated
Sales | $ | 3,672 |  |  | $ | — |  |  | $ | 3,672 |
Cost of sales | 1,151 |  |  | — |  |  | 1,151 |
Gross profit | 2,521 |  |  | — |  |  | 2,521 |
Other costs and expenses: |  |  |  |  |
Research and development | 613 |  |  | — |  |  | 613 |
Professional services | 628 |  |  | — |  |  | 628 |
Salaries and related costs | 2,119 |  |  | 51 |  |  | 2,170 |
Selling, general and administrative | 1,957 |  |  | (59 | ) |  | 1,898 |
Total other costs and expenses | 5,317 |  |  | (8 | ) |  | 5,309 |
Loss from operations | (2,796 | ) |  | 8 |  |  | (2,788 | )
Interest income (expense), net | 105 |  |  | — |  |  | 105 |
Other losses | (155 | ) |  | (713 | ) |  | (868 | )
Total other losses, net | (50 | ) |  | (713 | ) |  | (763 | )
Loss from continuing operations before income taxes | (2,846 | ) |  | (705 | ) |  | (3,551 | )
Income tax benefit | (2,408 | ) |  | — |  |  | (2,408 | )
Net loss from continuing operations | (438 | ) |  | (705 | ) |  | (1,143 | )
Income from discontinued operations, net of tax | 540 |  |  | — |  |  | 540 |
Gain on sale of the Core Business, net of tax | 69,072 |  |  | — |  |  | 69,072 |
Total income from discontinued operations, net of tax | 69,612 |  |  | — |  |  | 69,612 |
Net income (loss) | $ | 69,174 |  |  | $ | (705 | ) |  | $ | 68,469 |
Loss per share from continuing operations |  |  |  |  |
Basic and Diluted | $ | (0.01 | ) |  | $ | (0.02 | ) |  | $ | (0.03 | )
Income per share from discontinued operations |  |  |  |  |
Basic | 2.09 |  |  | — |  |  | 2.09 |
Diluted | 1.99 |  |  | — |  |  | 1.99 |
Income (loss) per share from all operations |  |  |  |  |
Basic | 2.08 |  |  | (0.02 | ) |  | 2.06 |
Diluted | 1.98 |  |  | (0.02 | ) |  | 1.96 |
Weighted average number of shares outstanding basic | 33,275 |  |  | 33,275 |  |  | 33,275 |
Weighted average number of shares outstanding diluted | 34,934 |  |  | 34,934 |  |  | 34,934 |
Consolidated Statement of Operations for the nine months ended September 30, 2018:
(In thousands) | As Originally Reported |  | Adjustments |  | As Restated
Sales | $ | 10,760 |  |  | $ | — |  |  | $ | 10,760 |
Cost of sales | 3,490 |  |  | — |  |  | 3,490 |
Gross profit | 7,270 |  |  | — |  |  | 7,270 |
Other costs and expenses: |  |  |  |  |
Research and development | 1,890 |  |  | — |  |  | 1,890 |
Professional services | 1,815 |  |  | — |  |  | 1,815 |
Salaries and related costs | 5,734 |  |  | 51 |  |  | 5,785 |
Selling, general and administrative | 6,280 |  |  | (59 | ) |  | 6,221 |
Total other costs and expenses | 15,719 |  |  | (8 | ) |  | 15,711 |
Loss from operations | (8,449 | ) |  | 8 |  |  | (8,441 | )
Interest income (expense), net | 33 |  |  | — |  |  | 33 |
Other losses | (155 | ) |  | (713 | ) |  | (868 | )
Change in fair value of derivative liabilities | 20 |  |  | — |  |  | 20 |
Total other losses, net | (102 | ) |  | (713 | ) |  | (815 | )
Loss from continuing operations before income taxes | (8,551 | ) |  | (705 | ) |  | (9,256 | )
Income tax benefit | (2,384 | ) |  | — |  |  | (2,384 | )
Net loss from continuing operations | (6,167 | ) |  | (705 | ) |  | (6,872 | )
Income from discontinued operations, net of tax | 5,062 |  |  | — |  |  | 5,062 |
Gain on sale of the Core Business, net of tax | 69,072 |  |  | — |  |  | 69,072 |
Total income from discontinued operations, net of tax | 74,134 |  |  | — |  |  | 74,134 |
Net income (loss) | $ | 67,967 |  |  | $ | (705 | ) |  | $ | 67,262 |
Loss per share from continuing operations |  |  |  |  |  |
Basic and Diluted | $ | (0.19 | ) |  | $ | (0.02 | ) |  | $ | (0.21 | )
Income per share from discontinued operations |  |  |  |  |
Basic | 2.25 |  |  | — |  |  | 2.25 |
Diluted | 2.19 |  |  | — |  |  | 2.19 |
Income (loss) per share from all operations |  |  |  |  |  |
Basic | 2.06 |  |  | (0.02 | ) |  | 2.04 |
Diluted | 2.00 |  |  | (0.02 | ) |  | 1.98 |
Weighted average number of shares outstanding basic | 33,014 |  |  | 33,014 |  |  | 33,014 |
Weighted average number of shares outstanding diluted | 33,952 |  |  | 33,952 |  |  | 33,952 |
Consolidated Balance Sheet as of December 31, 2018:
| (In thousands) | As Originally Reported |  | Adjustments |  | As Restated
| ASSETS |  |  |  |  |
| Current assets: |  |  |  |  |
| Cash and cash equivalents | $ | 16,466 |  |  | $ | 130 |  |  | $ | 16,596 |
| Short term investments | 61,678 |  |  | — |  |  | 61,678 |
| Trade accounts receivable, net** | 3,656 |  |  | 65 |  |  | 3,721 |
| Other receivables** | 1,359 |  |  | — |  |  | 1,359 |
| Inventories, net** | 3,061 |  |  | 85 |  |  | 3,146 |
| Prepaid expenses and other current assets** | 3,297 |  |  | 38 |  |  | 3,335 |
| Total current assets | 89,517 |  |  | 318 |  |  | 89,835 |
| Property and equipment, net | 5,788 |  |  | — |  |  | 5,788 |
| Other assets* | 305 |  |  | — |  |  | 305 |
| Total assets | $ | 95,610 |  |  | $ | 318 |  |  | $ | 95,928 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |
| Current liabilities: |  |  |  |  |
| Accounts payable | $ | 1,423 |  |  | $ | — |  |  | $ | 1,423 |
| Accrued expenses and other current liabilities* | 6,279 |  |  | 909 |  |  | 7,188 |
| Total current liabilities | 7,702 |  |  | 909 |  |  | 8,611 |
| Related party note payable | 140 |  |  | — |  |  | 140 |
| Total liabilities | 7,842 |  |  | 909 |  |  | 8,751 |
| STOCKHOLDERS' EQUITY |  |  |  |  |
| Common stock, $0.001 par value; 75,000,000 shares authorized; 33,847,100 issued and 33,704,525 outstanding | 34 |  |  | — |  |  | 34 |
| Additional paid-in capital | 52,221 |  |  | 699 |  |  | 52,920 |
| Retained earnings | 35,513 |  |  | (1,290 | ) |  | 34,223 |
| Total stockholders’ equity | 87,768 |  |  | (591 | ) |  | 87,177 |
| Total liabilities and stockholders’ equity | $ | 95,610 |  |  | $ | 318 |  |  | $ | 95,928 |
| * The Company has condensed the presentation of amounts presented in the balance sheet to conform to presentation guidelines.
| ** The Company has reclassified balances to conform to current presentation.
Consolidated Statement of Operations for the year ended December 31, 2018:
(In thousands) | As Originally Reported |  | Adjustments |  | As Restated
Sales | $ | 16,686 |  |  | $ | (81 | ) |  | $ | 16,605 |
Cost of sales | 5,893 |  |  | (114 | ) |  | 5,779 |
Gross profit | 10,793 |  |  | 33 |  |  | 10,826 |
Other costs and expenses: |  |  |  |  |
Research and development | 2,469 |  |  | 80 |  |  | 2,549 |
Professional services | 3,072 |  |  | 61 |  |  | 3,133 |
Salaries and related costs | 8,673 |  |  | 599 |  |  | 9,272 |
Selling, general and administrative | 9,438 |  |  | (31 | ) |  | 9,407 |
Severance and related expense | 741 |  |  | — |  |  | 741 |
Total other costs and expenses | 24,393 |  |  | 709 |  |  | 25,102 |
Loss from operations | (13,600 | ) |  | (676 | ) |  | (14,276 | )
Interest income | 616 |  |  | — |  |  | 616 |
Interest expense | (104 | ) |  | — |  |  | (104 | )
Other losses | (203 | ) |  | (744 | ) |  | (947 | )
Change in fair value of derivative liabilities | 20 |  |  | — |  |  | 20 |
Total other income (losses), net | 329 |  |  | (744 | ) |  | (415 | )
Loss from continuing operations before income taxes | (13,271 | ) |  | (1,420 | ) |  | (14,691 | )
Income tax benefit | (3,777 | ) |  | (130 | ) |  | (3,907 | )
Net loss from continuing operations | (9,494 | ) |  | (1,290 | ) |  | (10,784 | )
Income from discontinued operations, net of tax | 5,099 |  |  | — |  |  | 5,099 |
Gain on sale of the Core Business, net of tax | 68,404 |  |  | — |  |  | 68,404 |
Total income from discontinued operations, net of tax | 73,503 |  |  | — |  |  | 73,503 |
Net income (loss) | $ | 64,009 |  |  | $ | (1,290 | ) |  | $ | 62,719 |
Loss per share from continuing operations |  |  |  |  |  |
Basic and Diluted | $ | (0.29 | ) |  | $ | (0.04 | ) |  | $ | (0.32 | )
Income per share from discontinued operations |  |  |  |  |
Basic | 2.21 |  |  | — |  |  | 2.21 |
Diluted | 2.14 |  |  | — |  |  | 2.14 |
Income (loss) per share from all operations |  |  |  |  |  |
Basic | 1.93 |  |  | (0.04 | ) |  | 1.89 |
Diluted | 1.86 |  |  | (0.04 | ) |  | 1.83 |
Weighted average number of shares outstanding basic | 33,185 |  |  | 33,185 |  |  | 33,185 |
Weighted average number of shares outstanding diluted | 34,366 |  |  | 34,366 |  |  | 34,366 |
Consolidated Balance Sheet as of March 31, 2019:
| (In thousands) | As Originally Reported |  | Adjustments |  | As Restated
| ASSETS |  |  |  |  |
| Current assets: |  |  |  |  |
| Cash and cash equivalents | $ | 32,415 |  |  | $ | — |  |  | $ | 32,415 |
| Short term investments | 40,885 |  |  | — |  |  | 40,885 |
| Trade accounts receivable, net** | 4,006 |  |  | 38 |  |  | 4,044 |
| Other receivables** | 925 |  |  | — |  |  | 925 |
| Inventories, net** | 3,013 |  |  | — |  |  | 3,013 |
| Prepaid expenses and other current assets** | 3,996 |  |  | 38 |  |  | 4,034 |
| Total current assets | 85,240 |  |  | 76 |  |  | 85,316 |
| Property and equipment, net** | 6,015 |  |  | — |  |  | 6,015 |
| Operating lease right-of-use assets** | 178 |  |  | — |  |  | 178 |
| Other assets* | 270 |  |  | 77 |  |  | 347 |
| Total assets | $ | 91,703 |  |  | $ | 153 |  |  | $ | 91,856 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |
| Current liabilities: |  |  |  |  |
| Accounts payable | $ | 1,504 |  |  | $ | — |  |  | $ | 1,504 |
| Accrued expenses and other current liabilities* | 5,868 |  |  | 1,141 |  |  | 7,009 |
| Current portion of operating lease liabilities** | 103 |  |  | — |  |  | 103 |
| Total current liabilities | 7,475 |  |  | 1,141 |  |  | 8,616 |
| Related party note payable | 140 |  |  | — |  |  | 140 |
| Long-term portion of operating lease liabilities | 75 |  |  | — |  |  | 75 |
| Other long-term liabilities | — |  |  | 194 |  |  | 194 |
| Total liabilities | 7,690 |  |  | 1,335 |  |  | 9,025 |
| STOCKHOLDERS' EQUITY |  |  |  |  |
| Common stock, $0.001 par value; 75,000,000 shares authorized; 34,033,255 issued and 33,891,255 outstanding | 34 |  |  | — |  |  | 34 |
| Additional paid-in capital | 53,147 |  |  | 1,035 |  |  | 54,182 |
| Retained earnings | 30,832 |  |  | (2,217 | ) |  | 28,615 |
| Total stockholders’ equity | 84,013 |  |  | (1,182 | ) |  | 82,831 |
| Total liabilities and stockholders’ equity | $ | 91,703 |  |  | $ | 153 |  |  | $ | 91,856 |
| * The Company has condensed the presentation of amounts presented in the balance sheet to conform to presentation guidelines.
| ** The Company has reclassified balances to conform to current presentation.
Consolidated Statement of Operations for the three months ended March 31, 2019:
(In thousands) | As Originally Reported |  | Adjustments |  | As Restated
Sales | $ | 5,823 |  |  | $ | (194 | ) |  | $ | 5,629 |
Cost of sales | 2,103 |  |  | (37 | ) |  | 2,066 |
Gross profit | 3,720 |  |  | (157 | ) |  | 3,563 |
Other costs and expenses: |  |  |  |  |
Research and development | 810 |  |  | (80 | ) |  | 730 |
Professional services | 1,791 |  |  | 327 |  |  | 2,118 |
Salaries and related costs | 3,221 |  |  | 267 |  |  | 3,488 |
Selling, general and administrative | 3,101 |  |  | (144 | ) |  | 2,957 |
Total other costs and expenses | 8,923 |  |  | 370 |  |  | 9,293 |
Loss from operations | (5,203 | ) |  | (527 | ) |  | (5,730 | )
Interest income | 423 |  |  | — |  |  | 423 |
Other losses | (25 | ) |  | (270 | ) |  | (295 | )
Total other losses, net | 398 |  |  | (270 | ) |  | 128 |
Loss from continuing operations before income taxes | (4,805 | ) |  | (797 | ) |  | (5,602 | )
Income tax (benefit) expense | (124 | ) |  | 130 |  |  | 6 |
Net loss | $ | (4,681 | ) |  | $ | (927 | ) |  | $ | (5,608 | )
Loss per share |  |  |  |  |
Basic and Diluted | $ | (0.14 | ) |  | $ | (0.03 | ) |  | $ | (0.17 | )
Weighted average number of shares outstanding basic and diluted | 33,343 |  |  | 33,343 |  |  | 33,343 |
For the three months ended June 30, 2019:
(In thousands) | As Reported |  | Adjustments |  | As Revised |  |
Balance Sheet |  |  |  |  |  |  |
Trade accounts receivable, net | $ | 5,233 |  |  | $ | 59 |  |  | $ | 5,292 |  |  | [3]
Accrued and other liabilities | 6,149 |  |  | 1,081 |  |  | 7,230 |  |  | [1]
Retained earnings | 25,342 |  |  | (1,022 | ) |  | 24,320 |  |  | [1],[3]
Statement of Operations |  |  |  |  |  |  |
Sales | $ | 6,568 |  |  | $ | 81 |  |  | $ | 6,649 |  |  | [3]
Cost of sales | 2,096 |  |  | (121 | ) |  | 1,975 |  |  | [2],[3]
Professional services | 1,633 |  |  | 28 |  |  | 1,661 |  |  | [2]
Salaries and related costs | 3,333 |  |  | 177 |  |  | 3,510 |  |  | [2]
Selling, general and administrative | 3,083 |  |  | (46 | ) |  | 3,037 |  |  | [2]
Loss per share - all | $ | (0.13 | ) |  | $ | — |  |  | $ | (0.13 | ) |  | [2],[3]
Gross profit | 4,472 |  |  | 202 |  |  | 4,674 |  |  | [2]
Gross profit % | 68.1 | % |  | 2.2 | % |  | 70.3 | % |  | [2]
[1] Adjustments relate to payroll tax corrections |  |  |  |  |  |  |
[2] Adjustments relate to intercompany gross profit |  |  |  |  |  |  |
[3] Other corrections primarily related to balance sheet cutoff |  |  |  |  |  |  |
For the six months ended June 30, 2019:
(In thousands) | As Reported |  | Adjustments |  | As Revised |  |
Balance Sheet |  |  |  |  |  |  |
Trade accounts receivable, net | $ | 5,233 |  |  | $ | 59 |  |  | $ | 5,292 |  |  | [3]
Accrued and other liabilities | 6,149 |  |  | 1,081 |  |  | 7,230 |  |  | [1]
Retained earnings | 25,342 |  |  | (1,022 | ) |  | 24,320 |  |  | [1],[3]
Statement of Operations |  |  |  |  |  |  |
Sales | $ | 12,197 |  |  | $ | 81 |  |  | $ | 12,278 |  |  | [3]
Cost of sales | 4,199 |  |  | (158 | ) |  | 4,041 |  |  | [2],[3]
Research and development | 1,698 |  |  | (80 | ) |  | 1,618 |  |  | [2],[3]
Professional services | 3,760 |  |  | 19 |  |  | 3,779 |  |  | [2],[3]
Salaries and related costs | 6,671 |  |  | 327 |  |  | 6,998 |  |  | [1],[2]
Selling, general and administrative | 6,107 |  |  | (113 | ) |  | 5,994 |  |  | [2],[3]
Other income (losses), net | (225 | ) |  | (270 | ) |  | (495 | ) |  | [1],[3]
Loss per share - all | $ | (0.29 | ) |  | $ | (0.01 | ) |  | $ | (0.30 | ) |  | [1],[3]
Gross profit | 7,998 |  |  | 239 |  |  | 8,237 |  |  | [2],[3]
Gross profit % | 65.6 | % |  | 1.5 | % |  | 67.1 | % |  | [2],[3]
[1] Adjustments relate to payroll tax corrections |  |  |  |  |  |  |
[2] Adjustments relate to intercompany gross profit |  |  |  |  |  |  |
[3] Other corrections primarily related to balance sheet cutoff |  |  |  |  |  |  |
For the three months ended September 30, 2019:
(In thousands) | As Reported |  | Adjustments |  | As Revised |  |
Balance Sheet |  |  |  |  |  |  |
Accrued expenses and other liabilities | $ | 7,285 |  |  | $ | 1,081 |  |  | $ | 8,366 |  |  | [1]
Retained earnings | 21,031 |  |  | (1,081 | ) |  | 19,950 |  |  | [1]
Statement of Operations |  |  |  |  |  |  |
Cost of sales | $ | 2,558 |  |  | $ | (277 | ) |  | $ | 2,281 |  |  | [2]
Research and development | 936 |  |  | 80 |  |  | 1,016 |  |  | [2]
Professional services | 1,996 |  |  | 43 |  |  | 2,039 |  |  | [2]
Salaries and related costs | 3,020 |  |  | 139 |  |  | 3,159 |  |  | [2]
Selling, general and administrative | 3,762 |  |  | 74 |  |  | 3,836 |  |  | [2],[3]
Loss per share - all | $ | (0.13 | ) |  | $ | — |  |  | $ | (0.13 | ) |  | [3]
Gross profit | 5,017 |  |  | 277 |  |  | 5,294 |  |  | [2]
Gross profit % | 66.2 | % |  | 3.7 | % |  | 69.9 | % |  | [2]
[1] Adjustments relate to payroll tax corrections |  |  |  |  |  |  |
[2] Adjustments relate to intercompany gross profit |  |  |  |  |  |  |
[3] Other corrections primarily related to balance sheet cutoff |  |  |  |  |  |  |
For the nine months ended September 30, 2019:
(In thousands) | As Reported |  | Adjustments |  | As Revised |  |
Balance Sheet |  |  |  |  |  |  |
Accrued expenses and other liabilities | $ | 7,285 |  |  | $ | 1,081 |  |  | $ | 8,366 |  |  | [1]
Retained earnings | 21,031 |  |  | (1,081 | ) |  | 19,950 |  |  | [1]
Statement of Operations |  |  |  |  |  |  |
Sales | $ | 19,772 |  |  | $ | 81 |  |  | $ | 19,853 |  |  | [3]
Cost of sales | 6,757 |  |  | (435 | ) |  | 6,322 |  |  | [2],[3]
Research and development | 2,634 |  |  | — |  |  | 2,634 |  |  | [2],[3]
Professional services | 5,756 |  |  | 62 |  |  | 5,818 |  |  | [2],[3]
Salaries and related costs | 9,691 |  |  | 466 |  |  | 10,157 |  |  | [1],[2]
Selling, general and administrative | 9,869 |  |  | (39 | ) |  | 9,830 |  |  | [2],[3]
Other income (losses), net | 5 |  |  | (270 | ) |  | (265 | ) |  | [1],[3]
Loss per share - all | $ | (0.41 | ) |  | $ | (0.01 | ) |  | $ | (0.42 | ) |  | [1], [3]
Gross profit | 13,015 |  |  | 516 |  |  | 13,531 |  |  | [2],[3]
Gross profit % | 65.8 | % |  | 2.4 | % |  | 68.2 | % |  | [2],[3]
[1] Adjustments relate to payroll tax corrections |  |  |  |  |  |  |
[2] Adjustments relate to intercompany gross profit |  |  |  |  |  |  |
[3] Other corrections primarily related to balance sheet cutoff |  |  |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration